T-Cell Depletion, Donor HSCT, and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases

Conditions:   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Malignant Plasma Cell Neoplasms;   Myelodysplastic Syndromes;   Precancerous/Nonmalignant Condition;   Secondary MyelofibrosisInterventions:   Biological: peripheral blood lymphocyte therapy;   Drug: cyclophosphamide;   Drug: tacrolimus;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: total-body irradiationSponsors:   The Cleveland Clinic;   National Cancer Institute (NCI)Active, not recruiting - verified October 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials